Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rei Suzuki

Showing results (71-80 of 213) with videos related to

Pageof 22
Sort By:
Life (Basel, Switzerland)|June 28, 2023
Novel Photodynamic Therapy for Esophageal Squamous Cell Carcinoma following RadiotherapyTakumi Yanagita, Takuto Hikichi, Jun Nakamura, et al.
Fukushima Journal of Medical Science|September 11, 2018
Endoscopic ultrasound-guided fine needle aspiration for pancreatic cancerRei Suzuki, Tadayuki Takagi, Mitsuru Sugimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Erlotinib plus gemcitabine combination therapy in patients with unresectable advanced pancreatic cancer - a single-institution experience]Yutaka Takeda, Shin Nakahira, Yoshiteru Katsura, et al.
World Journal of Gastroenterology|November 30, 2016
Influence of night duty on endoscopic therapy for bile duct stonesMitsuru Sugimoto, Tadayuki Takagi, Rei Suzuki, et al.
European Journal of Human Genetics : EJHG|May 28, 2009
DNA methylation errors at imprinted loci after assisted conception originate in the parental spermHisato Kobayashi, Hitoshi Hiura, Rosalind M John, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 26, 2016
Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in pancreatic ductal adenocarcinomaYuichi Waragai, Rei Suzuki, Tadayuki Takagi, et al.
Japanese Journal of Clinical Oncology|July 19, 2005
Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cellsYujiro Fujie, Hirofumi Yamamoto, Chew Yee Ngan, et al.
Oncology Letters|April 29, 2016
Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancerRei Suzuki, Tadayuki Takagi, Takuto Hikichi, et al.
Anticancer Research|September 26, 2025
Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic CancerKentaro Sato, Rei Suzuki, Naoki Konno, et al.
Anticancer Research|February 27, 2022
The Complement C3a-C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal AdenocarcinomaRei Suzuki, Yoshinori Okubo, Tadayuki Takagi, et al.
Pageof 22

Showing results (71-80 of 213) with videos related to

Sort By:
Pageof 22
Life (Basel, Switzerland)|June 28, 2023
Novel Photodynamic Therapy for Esophageal Squamous Cell Carcinoma following RadiotherapyTakumi Yanagita, Takuto Hikichi, Jun Nakamura, et al.
Fukushima Journal of Medical Science|September 11, 2018
Endoscopic ultrasound-guided fine needle aspiration for pancreatic cancerRei Suzuki, Tadayuki Takagi, Mitsuru Sugimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Erlotinib plus gemcitabine combination therapy in patients with unresectable advanced pancreatic cancer - a single-institution experience]Yutaka Takeda, Shin Nakahira, Yoshiteru Katsura, et al.
World Journal of Gastroenterology|November 30, 2016
Influence of night duty on endoscopic therapy for bile duct stonesMitsuru Sugimoto, Tadayuki Takagi, Rei Suzuki, et al.
European Journal of Human Genetics : EJHG|May 28, 2009
DNA methylation errors at imprinted loci after assisted conception originate in the parental spermHisato Kobayashi, Hitoshi Hiura, Rosalind M John, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 26, 2016
Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in pancreatic ductal adenocarcinomaYuichi Waragai, Rei Suzuki, Tadayuki Takagi, et al.
Japanese Journal of Clinical Oncology|July 19, 2005
Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cellsYujiro Fujie, Hirofumi Yamamoto, Chew Yee Ngan, et al.
Oncology Letters|April 29, 2016
Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancerRei Suzuki, Tadayuki Takagi, Takuto Hikichi, et al.
Anticancer Research|September 26, 2025
Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic CancerKentaro Sato, Rei Suzuki, Naoki Konno, et al.
Anticancer Research|February 27, 2022
The Complement C3a-C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal AdenocarcinomaRei Suzuki, Yoshinori Okubo, Tadayuki Takagi, et al.
Pageof 22